Several studies show that the dysregulation of adiponectin and its receptors can be observed in the progression of multiple diseases, such as hypertension and T2DM, which are the risk factors for the occurrence and development of DN (Panduru et al., 2015). Here, ADIPOQ is linked to liver dysplastic nodule.